CliniExperts

CliniExperts Supports Successful Completion of the AMPLIFY-TIR Diabetes Study in India
18 Mar

CliniExperts Supports Successful Completion of the AMPLIFY-TIR Diabetes Study in India

Muskan SinghHealth, Press Release,
CliniExperts Supports Successful Completion of the AMPLIFY-TIR Diabetes Study in India New Delhi [India], March 18: We are pleased to announce the successful completion of the AMPLIFY-TIR Study, which evaluated fixed-dose combinations (FDCs) of sodium-glucose cotransporter-2 (SGLT2) inhibitors and dipeptidyl peptidase-4 (DPP-4) inhibitors in Indian patients with type 2 diabetes mellitus (T2DM) using continuous glucose monitoring (CGM). This prospective, randomised, open-label, triple-arm clinical study conducted across six centres in India included 90 adults with T2DM on stable metformin therapy who were randomised to receive teneligliptin + dapagliflozin, sitagliptin + dapagliflozin, or linagliptin + empagliflozin. CliniExperts Research served as the Indian arm Contract…
Read More
CliniExperts Conducts Successful Study, Affirming ALFLUTOP’s Benefits for Indian Osteoarthritis Patients
29 Jan

CliniExperts Conducts Successful Study, Affirming ALFLUTOP’s Benefits for Indian Osteoarthritis Patients

Muskan SinghHealth, Press Release, ,
New Delhi [India], January 28: CliniExperts, one of India’s premier Clinical Research Organizations, successfully conducted a phase III study on its biotherapeutic product, ALFLUTOP®, to assess the efficacy, safety, and tolerability in Indian patients with knee osteoarthritis. Such a scientific study proved ALFLUTOP® not just efficacious but could help in drastically improving the quality of life of patients in India, where osteoarthritis increasingly becomes a huge public health problem. The study sought to fill a significant void in the current literature concerning the efficacy of ALFLUTOP® within the Indian demographic. Although the product has been available in the market for…
Read More